Androgen deprivation therapy for prostate cancer:not so simple
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
Prostate cancer(PC)is the second most diagnosed visceral malignancy in men worldwide, with over 900 000 new diagnoses each year.1 Approximately 50% of patients treated in industrialized nations will receive androgen deprivation therapy(ADT)at some point in their lifetimes.2